J. L. Bainbridge & Co., Inc. Pfizer Inc Transaction History

J. L. Bainbridge & Co., Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $3,144 - $3,675	98 Added 1.65%	6,040 $200,000
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $108 - $125	3 Added 0.05%	5,942 $217,000
Q1 2023 May 04, 2023	SELL	$39.39 - $51.28 $196 - $256	-5 Reduced 0.08%	5,939 $242,000
Q4 2022 Jan 27, 2023	BUY	$41.75 - $54.5 $7,306 - $9,537	175 Added 3.03%	5,944 $0
Q3 2022 Nov 02, 2022	BUY	$43.76 - $53.42 $43,847 - $53,526	1,002 Added 21.02%	5,769 $252,000
Q2 2022 Aug 04, 2022	BUY	$46.53 - $55.17 $11,679 - $13,847	251 Added 5.56%	4,767 $250,000
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $18,254 - $22,619	-399 Reduced 8.12%	4,516 $234,000
Q4 2021 Feb 07, 2022	BUY	$41.32 - $61.25 $4,875 - $7,227	118 Added 2.46%	4,915 $290,000
Q3 2021 Oct 28, 2021	BUY	$39.25 - $50.42 $188,282 - $241,864	4,797 New	4,797 $206,000
Q1 2020 May 12, 2020	SELL	$27.03 - $38.62 $160,774 - $229,711	-5,948 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $4,970 - $5,641	151 Added 2.6%	5,948 $233,000
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $9,941 - $12,891	306 Added 5.57%	5,797 $208,000
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $70,631 - $79,303	-1,910 Reduced 25.81%	5,491 $238,000
Q1 2019 May 14, 2019	SELL	$37.5 - $41.2 $60,225 - $66,167	-1,606 Reduced 17.83%	7,401 $308,000
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $269 - $307	7 Added 0.08%	9,007 $393,000
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $310,230 - $376,290	9,000 New	9,000 $397,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of J. L. Bainbridge & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on J. L. Bainbridge & Co., Inc. with notifications on news.